Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Intervention: Drug: Tolvaptan Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials